Summary & Overview

HCPCS G9450: History of Injection Drug Use

HCPCS Level II code G9450 documents a documented history of injection drug use in a patient’s medical record. Nationally, clear capture of substance use history supports clinical decision-making, care coordination, risk stratification, and public health surveillance. Accurate use of G9450 can affect quality reporting and care pathways for patients with prior injection drug exposure.

Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the code’s clinical context, the typical settings where it is reported, and what to expect in payer coverage patterns. The publication outlines common administrative considerations, coding relationships, and the implications for documentation and reporting workflows.

This resource summarizes benchmarks and common billing practices for G9450, highlights relevant policy updates affecting HCPCS Level II social and behavioral health categories, and provides clinical context to help billing teams and compliance staff align documentation with the code’s intended use.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareG9450HCPCS Level IIhistory of injection drug usesubstance use documentationbehavioral health codingambulatory caremedical record documentation

Billing Code Overview

HCPCS Level II code G9450 indicates a history of injection drug use. This code is used to document a patient record element reflecting past injection drug use as part of clinical and administrative documentation.

Service type: Behavioral health / substance use history assessment
Typical site of service: Outpatient clinic, behavioral health clinic, primary care office, or other ambulatory settings

Clinical & Coding Specifications

Clinical Context

A 34-year-old person presents to a community health clinic for an intake visit focused on substance use history and related risk assessment. The patient discloses previous injection drug use during episodic opioid misuse several years prior and requests screening for bloodborne infections, counseling about wound care, and referral to harm reduction services. The clinical workflow includes intake registration, review of past medical and social history, targeted substance-use history documentation (including frequency, substances injected, sharing of equipment, and date of last injection), focused physical exam of injection sites, ordering of laboratory testing (HIV antigen/antibody, Hepatitis B surface antigen and core antibody, Hepatitis C antibody and RNA), provision of wound care or immunizations as indicated (tetanus, Hepatitis B vaccine series if susceptible), counseling and referral to syringe services, and documentation of the history of injection drug use using billing code G9450 on the claim. Typical encounter sites are outpatient clinics, community health centers, syringe service programs, and emergency departments performing intake and risk assessment. The typical patient scenario includes linkage to specialty care (infectious disease or addiction medicine) when testing is positive or when the patient requests treatment for substance use disorder.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased Procedural Services	Use when work required is substantially greater than typically required for the service due to complexity of assessment or extended counseling related to injection drug use.
`23`	Unusual Anesthesia	Use if general anesthesia or regional blocks are required for a related procedure in the same encounter (rare for this service).
`52`	Reduced Services	Use when a service is partially reduced or not completed (for example, incomplete counseling or testing due to patient leaving).
`53`	Discontinued Procedure	Use if the assessment or related procedure is started but terminated due to patient instability or other valid reason.
`54`	Surgical Care Only	Use when the provider bills only for the surgical component and another bills postoperative care (not commonly used for this code).
`55`	Postoperative Management Only	Use when the provider bills only for postoperative care following a procedure related to injection complications.
`56`	Preoperative Management Only	Use when only preoperative evaluation is billed prior to a procedure addressing injection-related complications.
`62`	Two Surgeons	Use when two surgeons are required for a complex operative procedure addressing complications from injection drug use.
`AS`	Physician Assistant, Nurse Practitioner, or Clinical Nurse Specialist Services for an Assistant at Surgery	Use when an advanced practice clinician serves in an assistant role during a surgical procedure related to injection complications.
`CQ`	Service Delivered Under a Rural Health Clinic (RHC) or Federally Qualified Health Center (FQHC) Demonstration	Use when service is furnished under the RHC/FQHC demonstration model.

Taxonomy Code	Specialty	Notes
`163W00000X`	Addiction Medicine Specialist	Manages substance use disorder treatment and linkage to care.
`2084P0800X`	Emergency Medicine Physician	Commonly documents acute presentations and initial risk assessment for injection drug users.
`208D00000X`	Family Medicine Physician	Performs comprehensive intake, screening, vaccination, and referrals in outpatient settings.
`367500000X`	Public Health Professional	Works in community programs and syringe services providing harm reduction and documentation.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`Z72.3`	Lack of physical exercise	Data not available in the input.
`F11.20`	Opioid dependence, uncomplicated	Commonly associated when patients report injection drug use involving opioids; relevant for treatment planning and addiction referral.
`F19.20`	Other psychoactive substance dependence, uncomplicated	Used when injection relates to stimulants or other non-opioid substances requiring substance use services.
`B20`	Human immunodeficiency virus [HIV] disease	Injection drug use is a risk factor for HIV; positive HIV status changes testing and linkage workflows.
`B18.2`	Chronic viral hepatitis C	Injection drug use is the primary risk factor for hepatitis C infection; mandates screening and possible RNA testing.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`36415`	Collection of venous blood by venipuncture	Often performed to obtain specimens for HIV, Hepatitis B and C testing after documenting history of injection drug use.
`87635`	Infectious agent detection by nucleic acid (DNA or RNA); SARS-CoV-2 (this is an example — not typically related)	Data not available in the input.
`80053`	Comprehensive metabolic panel	Commonly ordered alongside infectious disease testing to assess baseline organ function prior to antiviral or addiction treatment.
`99406`	Smoking and tobacco use cessation counseling visit, intermediate, greater than 3 minutes up to 10 minutes	Behavioral counseling CPT used as a proximate example for brief counseling interventions addressing substance use; may be billed when counseling is provided.
`90707`	Tetanus toxoid (specified formulation)	Immunizations such as tetanus or Hepatitis B vaccine administration are commonly performed when gaps in immunization are identified during the visit.